Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction
Journal of Digestive Diseases · 2023
DOI: 10.1111/1751-2980.13167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2023. Verfasst von Qin Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Objectives
We followed The Cancer Genome Atlas (TCGA) grouping criteria and conducted a clinicopathological cohort study in a unique patient population to gain insight into the pathobiology of esophageal adenocarcinoma (EAC) and adenocarcinoma of the gastroesophageal junction (AGEJ).
Methods
We studied and statistically compared the clinicopathological and prognostic features of both cancers in 303 consecutive patients treated at the Veterans Affairs Boston Healthcare System over a 20‐year period using uniform criteria and standardized routines.
Results
Over 99% of patients were white men with a mean age of 69.1 years and an average body mass index (BMI) of 28.0 kg/m 2 . No significant differences were detected in age, gender, ethnicity, BMI, and history of tobacco abuse between the two groups. Compared to AGEJ patients, a significantly higher proportion of EAC patients had gastroesophageal reflux disease, long‐segment Barrett's esophagus, common adenocarcinoma type, smaller tumor size, better differentiation, more stages I or II but fewer stages III or IV diseases, scarcer lymph node invasion, fewer distant metastases, and better overall, disease‐free, and relapse‐free survival. The 5‐year overall survival rate was significantly higher in EAC patients than in AGEJ patients (41.3% vs 17.2%, P < 0.001). This improved survival among EAC patients remained significant after censoring all cases detected during endoscopic surveillance, suggesting different pathogenesis mechanisms between EAC and AGEJ.
Conclusions
EAC patients showed significantly better outcomes than AGEJ patients. Our results require validation in other patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
- Previously at the Department of Pathology and Laboratory Medicine, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA.
- Department of Pathology, The Affiliated Changzhou N0.2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
- Department of Gastroenterology, Veterans Affairs Boston Healthcare System, Harvard Medical School/Brigham and Women's Hospital, West Roxbury, Massachusetts, USA.
- Department of Pathology, Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China.
- Department of Thoracic Surgery, Veterans Affairs Boston Healthcare System, Harvard Medical School/Brigham and Women's Hospital, West Roxbury, Massachusetts, USA.
ORCID-Profile: Qin Huang
Zitieren
APA
Huang, Q., Cheng, Y., Lew, E., Shi, J., Wiener, D., & Weber, H. C. (2023). Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13167
Vancouver
Huang Q, Cheng Y, Lew E, Shi J, Wiener D, Weber HC. Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction. Journal of Digestive Diseases. 2023. doi:10.1111/1751-2980.13167
BibTeX
@article{Huang2023,
author = {Huang, Qin and Cheng, Yuqing and Lew, Edward and Shi, Jiong and Wiener, Daniel and Weber, H Christian},
title = {Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction},
journal = {Journal of Digestive Diseases},
year = {2023},
doi = {10.1111/1751-2980.13167}
}
EUVIMED